BRCA2 and breast cancer: In this study, pathogenic mutations were identified in 135 patients most of them in the BRCA1/2 gene.The mutation carrier rate was higher than the unselected BC patients (19.5% vs 5.3%).15 Mutations found in the BRCA1 gene (14.6%) in this cohort were almost three times higher compared to BRCA2 (5%).